NCT01577732 - Safety of GSK Biologicals' Infanrix-IPV+HibTM Vaccine in Healthy Vietnamese Toddlers | Biotech Hunter

Enrollment

321

Participants

Timeline

Start Date

December 8, 2012

Primary Completion Date

April 9, 2013

Study Completion Date

April 9, 2013

Conditions

Acellular PertussisHaemophilus Influenzae Type bTetanusPoliomyelitisDiphtheriaDiphtheria-Tetanus-aPertussis-Poliomyelitis-Haemophilus Influenzae Type b Vaccines

Interventions

BIOLOGICAL

Infanrix-IPV+Hib™

Single dose administered intramuscularly (IM) into the anterolateral side of the right thigh.

Trial Locations (1)

Unknown

GSK Investigational Site, Haiphong